Strikingly, among these, neurotrophin signaling [17,18], MTA-3 downregulation (Table 3) [19], cell cycle deregulation [20], and glycolysis/gluconeogenesis [21] have been implicated in the development and progression of melanoma and other cancers. The gene discussed is MTA3; the disease is melanoma.